Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative ...

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

The evolving needs of Indian pharma industry encompass advanced skills in areas like biologics, AI, and automation ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imaging analysis technologies, ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...